Body Mass Index (BMI) at Time of Diagnosis As a Prognostic Indicator in Patients with Newly Diagnosed Glioblastoma (GBM)

Patient baseline BMI <25 appears to be a prognostic indicator and correlates to improves overall survival for patients with newly diagnosed GBM. This study adds to the existing literature supporting overweight/obesity is associated with worse survival for GBM patients. Additional studies are warranted for further analysis of BMI and survival outcomes in GBM patients across patient demographics.